Loading clinical trials...
Loading clinical trials...
The COVID-19 pandemic represents a threat to rheumatology patients. National advice for patients to 'shield' is based on risk stratification of therapies and other risk factors. While the epidemiology...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The Royal Wolverhampton Hospitals NHS Trust
NCT00024479 · Rheumatic Diseases, Arthritis
NCT07469787 · Chronic Inflammatory Rheumatic Diseases of Childhood, Juvenile-Onset Chronic Inflammatory Rheumatic Diseases, and more
NCT04402086 · Rheumatic Diseases, Adult Onset Still Disease, and more
NCT07189936 · Post-Acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS), and more
NCT04525716 · Covid19, Surgery
The Royal Wolverhampton NHS Trust
Wolverhampton, West Midlands
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions